![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2017
Paprottka, K. J.; Schoeppe, F.; Ingrisch, M.; Rübenthaler, J.; Sommer, N. N.; Toni, E. de; Ilhan, H.; Zacherl, M.; Todica, A. und Paprottka, P. M.
(2017):
Pre-therapeutic factors for predicting survival after radioembolization: a single-center experience in 389 patients.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 7: S. 1185-1193
2016
Hartenbach, M.; Weber, S.; Hartenbach, S.; Zacherl, M.; Papprottka, P. M.; Tiling, R.; Bartenstein, P.; Hacker, M.; Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624 und Haug, A.
(2016):
Prognoctic value of combined [(99m)]Tc-MAA-SPECT/CT and [F-18]Fluorethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S17-S17
ORCID: https://orcid.org/0000-0003-0953-7624 und Haug, A.
(2016):
Prognoctic value of combined [(99m)]Tc-MAA-SPECT/CT and [F-18]Fluorethylcholine-PET/CT in patients suffering from advanced hepatocellular carcinoma prior to radioembolization.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S17-S17